Ciprofloxacin for treatment of tularemia.
نویسندگان
چکیده
Reply Sir—We would like to address Dr. Ise-man's concern [1] that our study [2] may be misleading. Dr. Iseman expresses his concern by emphasizing the absence of evidence that slow conversion of sputum smear results from positive to negative status is associated with an increased risk for transmission of Mycobacterium tuberculosis , treatment failure, and acquired drug resistance so long as appropriate therapy is maintained. We wish to stress that the patients in our study were expectorating high concentrations of viable organisms for months on end. Even in the absence of published evidence to the contrary, we would consider it cavalier to assume that such patients did not pose a risk to others in the community. Where the reader may be misled is in assuming that our study proved that our intervention prevented transmission. We do, however, respectfully suggest that the absence of positive stain and culture results for many months is somewhat reassuring. Whether the patients in our study had " treatment failure " depends on the definition of the term. We do not dispute that, for many patients with multidrug-resistant tuberculosis, positive sputum smear results ultimately convert to negative when the patients receive only conventional therapy. Unfortunately, the prolonged interval of sputum smear pos-itivity and the requirement for protracted therapy, with the attendant problems of infectiousness, poor compliance, and development of drug resistance, are part of a global failure of tuberculosis management , if not a failure in the treatment of specific individuals. Although our intention was not to promote the use of aerosol therapy on the basis of our very preliminary evidence, we believe that the disruption to patients' lives and the expense that occur as a result of this intervention (if it is confirmed to be effective in future studies) compete favorably with the punitive and costly isolation requirements supported by the Centers for Disease Control and Prevention (Atlanta) for patients with tuberculosis who have persistently positive sputum smear results [3]. We did not in any way wish to imply that aerosol therapy should be considered a substitute for systemic therapy. For no patient was traditional treatment abandoned once sterilization of secretions in the airways was achieved. We fully agree that aerosol therapy is unlikely to have any impact on organisms that are buried in the lymphatic system and the walls of the airways. However, we suggest that the presence of viable organisms in sputum is …
منابع مشابه
The potential of liposome–encapsulated ciprofloxacin as a tularemia therapy
Liposome-encapsulation has been suggested as method to improve the efficacy of ciprofloxacin against the intracellular pathogen, Francisella tularensis. Early work with a prototype formulation, evaluated for use against the F. tularensis live vaccine strain, showed that a single dose of liposomal ciprofloxacin given by the intranasal or inhalational route could provide protection in a mouse mod...
متن کاملTreatment-failure tularemia in children
Purpose Tularemia is an infection caused by Francisella tularensis. Its diagnosis and treatment may be difficult in many cases. The aim of this study was to evaluate treatment modalities for pediatric tularemia patients who do not respond to medical treatment. Methods A single-center, retrospective study was performed. A total of 19 children with oropharyngeal tularemia were included. Resul...
متن کاملOsteonecrosis in human immunodeficiency virus-infected patients may not be related to immune reconstitution.
with ciprofloxacin at a dosage of 500–750 mg b.i.d. for 10–28 days. It should be noted, however, that, in the latter report, the interval between onset of disease and start of treatment with ciprofloxacin was not specified, and, in 4 of 7 cases with relapse, ciprofloxacin was used as a secondary therapy. We recently reported successful treatment of ulceroglandular tularemia with oral ciprofloxa...
متن کاملClinical recognition and management of tularemia in Missouri: a retrospective records review of 121 cases.
BACKGROUND Clinical recognition of tularemia is essential for prompt initiation of appropriate antibiotic treatment. Although fluoroquinolones have desirable attributes as a treatment option, limited data on efficacy in the US setting exist. METHODS To define the epidemiology of tularemia in Missouri, and to evaluate practices and outcomes of tularemia management in general, we conducted a de...
متن کاملOropharyngeal tularemia cases admitted to a military hospital in Ankara, Turkey.
INTRODUCTION This study aimed to review the possible sources of infection of 16 oropharyngeal tularemia hospital cases, and to document their epidemiological and demographical characteristics, laboratory findings, treatment methods, and treatment results. METHODOLOGY Sixteen cases from a Turkish military hospital between January 2011 and December 2012 were retrospectively evaluated. The age, ...
متن کاملTularemia epidemic in northwestern Spain: clinical description and therapeutic response.
This study describes the clinical characteristics of tularemia in Spain's first epidemic outbreak and the therapeutic response and compares the efficacy of 3 antibiotics (streptomycin, ciprofloxacin, and doxycycline). For 142 cases of tularemia, the therapeutic failure rate was 22.5%; ciprofloxacin was the antibiotic with the lowest percentage of therapeutic failures and with the fewest side ef...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
دوره 33 2 شماره
صفحات -
تاریخ انتشار 2001